KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Efficacy and safety of secukinumab in patients with active psoriatic arthritis at Week 16 and up to 52 weeks: Results from a Phase III, randomized, double-blind, placebo-controlled bridging study in China.

Xiaomei Leng, Yi Liu, Lin Tang, Lingyun Sun, Jingyang Li, Jiankang Hu, Hongbin Li, Shanhui Ye, Lijun Wu, Xinwang Duan, Huaxiang Liu, Ting Li, Yongfu Wang, Mercedes Bustamante, Sharonjeet Kaur, Rong Fu, Yuan Tian, Jing Yang, Pellet Pascale, Xiaofeng Zeng

Chin Med J (Engl) 10.1097/CM9.0000000000003924

PMID41872105
PMCID-
DOI10.1097/CM9.0000000000003924
发表日期2026-03-24
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。